Not Yet RecruitingNot Applicable

Evaluation of a Remote Behavioural Stress Recovery Intervention for Myocardial Infarction Patients Younger Than Fifty-five (BRIM-55): A Feasibility Study

Sweden30 participantsStarted 2026-08-24

Plain-language summary

The goal of this feasibility study is to learn if the randomised controlled trial evaluating the Remote-delivery Balance in Everyday Life (rBEL) programme for adults younger than 55 years who have experienced a myocardial infarction (MI), is feasible. The objective is to examine the feasibility of the rBEL programme and the associated study procedures before a controlled evaluation of the programme. This is an uncontrolled, single-arm, pre-post treatment designed study. Participants of the target population will take part of the six session over 13 week programme. Feasibility will be evaluated against predefined feasibility criteria regarding study procedures and programme acceptability.

Who can participate

Age range

18 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Myocardial infarction (MI) before age 55 years * MI within one year prior to randomization * Report of subjective cardiac distress in the initial interview Exclusion criteria: * Serious conditions hindering participation (e.g., active substance misuse, severe mental illness) * Insufficient Swedish proficiency for study procedures, * Disability pension or early retirement at the time of MI

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Recruitment

Timeframe: Six weeks from when the invitation letter was sent out

Acceptability

Timeframe: Four weeks from the screening interview

Participant adherence

Timeframe: From start of intervention to 12 weeks later.

Retention

Timeframe: From the end of the intervention to two weeks later.

Adverse events

Timeframe: From intervention start to four weeks after intervention end.

Program credibility

Timeframe: Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.

Program satisfaction

Timeframe: From the end of the intervention to two weeks later.

Trial details

NCT IDNCT07706816

SponsorUppsala University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01-31

Contact for this trial

Erik MG Olsson, Professor

+46729999210 erik.mg.olsson@uu.se

View on ClinicalTrials.gov More Cardiac Disease trials

Plain-language summary

Who can participate

Age range

18 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Recruitment

Timeframe: Six weeks from when the invitation letter was sent out

Acceptability

Timeframe: Four weeks from the screening interview

Participant adherence

Timeframe: From start of intervention to 12 weeks later.

Retention

Timeframe: From the end of the intervention to two weeks later.

Adverse events

Timeframe: From intervention start to four weeks after intervention end.

Program credibility

Timeframe: Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.

Program satisfaction

Timeframe: From the end of the intervention to two weeks later.